Pfizer ( PFE ) recently entered into two deals. While one deal was signed with biopharma company Halozyme Therapeutics, Inc. ( HALO ), the second deal was signed with clinical
Stocks spent most of the session in the red, thanks to lackluster retail sales data and lingering concerns about falling off the fiscal cliff. “Volume was very light today, but the selling